Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Selecta Biosciences Inc.
DescriptionSynthetic vaccine particle adjuvant that induces antibodies to nicotine
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAddiction
Indication DetailsSmoking cessation and relapse prevention
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today